Design, synthesis, and evaluation of novel indomethacin-antioxidant codrugs as gastrosparing NSAIDs

Medicinal Chemistry Research

Volumn 21, Issue 6, 2012, Pages 834-843

  Sawraj, Shruti ^a   Bhardawaj, Tilak R ^a   Sharma, Pritam D ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antioxidant; Codrug; Indomethacin; NSAIDs; Ulcerogenicity

Indexed keywords

INDOMETHACIN PLUS EUGENOL; INDOMETHACIN PLUS GUAIACOL; INDOMETHACIN PLUS MENTHOL; INDOMETHACIN PLUS SESAMOL; INDOMETHACIN PLUS THYMOL; INDOMETHACIN PLUS UMBELLIFERONE; INDOMETHACIN PLUS VANILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 84861860937     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9589-1     Document Type: Article

References (28)

1. Bandyopadhyay U, Das D, Banerjee RK (1999) Reactive oxygen species-oxidative damage and pathogenesis. Curr Sci 77:658-665
2. Bhosle D, Bharambe S, Garrola N, Dhaneshwar SS (2006) Mutual prodrug concept: fundamentals and applications. Indian J Pharma Sci 68:286-294 (Pubitemid 44195878)
3. Cioli V, Putzolu S, Rossi V, Barcellona SP, Corradino C (1979) The role of direct tissue contact in the production of gastro-intestinal ulcer by antiinflammatory drugs in rats. Toxicol Appl Pharmacol 50:283-289 (Pubitemid 10233388)
4. Cotelle N (2001) Role of flavonoids in oxidative stress. Curr Top Med Chem 1:569-590
5. Dogne JM, Supuran CT, Pratico D (2005) Adverse cardiovascular effects of coxibs. J Med Chem 48:2251-2257
6. Doulgkeris CM, Galanakis D, Kourounakis AP, Tsiakitzis KC, Gavalas AM, Eleftheriou PT, Victoratos P, Rekka EA, Kourounakis PN (2006) Synthesis and pharmacochemical study of novel polyfunctional molecules combining antiinflammatory, antioxidant, and hypocholesterolemic properties. Bioorg Med Chem Lett 16:825-829 (Pubitemid 43059831)
7. Gibson T (1988) Nonsteroidal antiinflammatory drugs-another look. Br J Rheumatol 27:87-90
8. Hassan A, Martin E, Puig-Parellada P (1998) Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find Exp Clin Pharmacol 20:849-854 (Pubitemid 29102376)
9. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307-314 (Pubitemid 29089366)
10. Hla T, Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384-7388
11. Jimenez MJ, Alcaraz MJ (1988) Flavonoids as antiinflammatory agents. Fitoterapia 59:25-38
12. Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412
13. Leppanen J, Huuskonen J, Nevalainen T, Gynther J, Taipale H, Jarvinen T (2002) Design and synthesis of a novel L-dopa entacapone codrug. J Med Chem 45:1379-1382 (Pubitemid 34263574)
14. Martin MJ, La-casa C, Alarcon-de-la-Lastra C, Cabeza J, Villegas J, Motilva Y (1998) Anti-oxidant mechanisms involved in gastroprotective effects of quercetin. Z Naturforsch C 53:82-88 (Pubitemid 28111161)
15. Mc Carthy MD (1989) Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 96:662-674
16. Nakatani M (2000) Phenolic antioxidants from herbs and spices. Biofactors 13:141
17. Repetto MG, Llesuy SF (2002) Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Br J Med Biol Res 35:523-534 (Pubitemid 34568220)
18. Sawraj S, Bhardawaj TR, Sharma PD (2010) Design, synthesis and evaluation of novel indomethacin-flavonoid mutual prodrugs as safer NSAIDs. Med Chem Res. doi:10.1007/s00044-010-9363-9
19. Schnitzer TJ (2001) COX-2-specific inhibitors: are they safe? J Am Med 110:46-49
20. Singh G, Sharma PD (1994) Mutual prodrugs-a recent trend in prodrug design. Indian J Pharm Sci 56:69-79 (Pubitemid 24213983)
21. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235
22. Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47:S78-S87 (Pubitemid 28493273)
23. Warner TD, Giuliano F, Vojnovic I, Bukada A, Mitchell JA, Vane JR (1999) Nonsteroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity-a full in vitro analysis. Proc Natl Acad Sci USA 96:7563-7568 (Pubitemid 29299702)
24. Winter CA, Risley GA, Nuss GW (1962) Carrageenan induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 3:544-547
25. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of non steroidal antiinflammatory drugs. N Engl J Med 340:1888-1899 (Pubitemid 29272670)
26. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692-2696 (Pubitemid 21916484)
27. Xie W, Robertson DL, Simmons DL (1992) Mitogen-inducible prostaglandin G/H synthase: a new target to be a potential source of inhibitors of NF-jB activation. Drug Dev Res 25:249-265
28. Zhang Y, Chen P, Guan H, Li Y (2005) Synthesis and pharmacological evaluation of novel conjugates of indomethacin with antioxidant activity. Chinese J Chem 23:1523-1529 (Pubitemid 41767921)